SpyGlass Pharma, Inc. (SGP)

Sentiment-Signal

47,9

Neutral

Composite Score (0–100)

Insider (25%)

91.3

15 Insider, 221,5M $ Volumen

Institutionell (22,5%)

Keine neuen Positionen

Aktivist (12,5%)

92.2

13D-Filing vorhanden

Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)

Score-Verlauf (90 Tage)

Stammdaten

SpyGlass Pharma, Inc. is a late-stage biopharmaceutical, which engages in the development of treatment paradigm for patients living with chronic eye conditions. Its lead product candidate, Bimatoprost Drug Pad-IOL System (BIM-IOL System), is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) for patients who have wither open-angel glaucoma (OAG) or ocular hypertension (OHT). The company was founded in January 2019 by Malik Y. Kahook and Glenn Sussman and is headquartered in Aliso Viejo, CA.

Unternehmen & Branche

Name	SpyGlass Pharma, Inc.
Ticker	SGP
CIK	0001778922
Boerse	US
Sektor	Healthcare
Industrie	Biotechnology
SIC	3841 · Surgical & Medical Instruments & Apparatus

Wertpapier & Kennzahlen

CUSIP	85220G109
ISIN	US85220G1094
Typ	Common Stock
Marktkapitalisierung	741,1 Mio. USD
Beta	0,00
Dividendenrendite	0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

Periode	Filing	Umsatz	Nettoergebnis	EPS	Aktiva	Eigenkapital
2025-12-31	10-K		-39,869,000	-17.98	115,866,000	-98,837,000
2024-12-31	10-K		-29,164,000	-16.31	23,318,000	-60,474,000

Fondsaktivität (Vorquartalsvergleich)

Keine Fondsdaten für dieses Unternehmen vorhanden.

Insider-Transaktionen (12 Monate)

Datum	Insider	Rolle	Typ	Stückzahl	Kurs	Wert (USD)	Δ
2026-02-09	Nielsen Kirk G.	Director	Open Market Purchase	165,000	16.00	2,640,000.00	+20,3%
2026-02-09	Vensana Capital I GP, LLC	10% Owner	Open Market Purchase	165,000	16.00	2,640,000.00	+20,3%
2026-02-09	SANDELL SCOTT D	10% Owner	Open Market Purchase	937,500	16.00	15,000,000.00	+115,1%
2026-02-09	Makhzoumi Mohamad	10% Owner	Open Market Purchase	937,500	16.00	15,000,000.00	+115,1%
2026-02-09	Florence Anthony A. Jr.	10% Owner	Open Market Purchase	937,500	16.00	15,000,000.00	+115,1%
2026-02-09	Chang Carmen	10% Owner	Open Market Purchase	937,500	16.00	15,000,000.00	+115,1%
2026-02-09	BASKETT FOREST	10% Owner	Open Market Purchase	937,500	16.00	15,000,000.00	+115,1%
2026-02-09	Pardo Geoffrey B	Director	Open Market Purchase	312,500	16.00	5,000,000.00	+38,4%
2026-02-09	Khan Bilal Arshad	Director	Open Market Purchase	20,000	16.00	320,000.00	+2,5%
2026-02-09	Khan Bilal Arshad	Director	Open Market Purchase	115,000	16.00	1,840,000.00	+14,1%
2026-02-09	Walker Paul Edward	10% Owner	Open Market Purchase	937,500	16.00	15,000,000.00	+115,1%
2026-02-09	Mathers Edward T	10% Owner	Open Market Purchase	937,500	16.00	15,000,000.00	+115,1%
2026-02-09	Behbahani Ali	Director, 10% Owner	Open Market Purchase	937,500	16.00	15,000,000.00	+115,1%
2026-02-09	Yang Rick	10% Owner	Open Market Purchase	937,500	16.00	15,000,000.00	+115,1%
2026-02-09	New Enterprise Associates 17, L.P.	10% Owner	Open Market Purchase	937,500	16.00	15,000,000.00	+115,1%
2026-02-09	RA CAPITAL MANAGEMENT, L.P.	Director, 10% Owner	Open Market Purchase	248,034	16.00	3,968,544.00	+30,5%
2026-02-09	RA CAPITAL MANAGEMENT, L.P.	Director, 10% Owner	Open Market Purchase	3,441,966	16.00	55,071,456.00	+422,7%

Fail-to-Deliver (6 Monate)

Datum	FTD-Menge	Kurs	Wert (USD)
2026-03-31	1.372	23,37	32.064
2026-03-30	48.293	22,61	1.091.905
2026-03-27	52.246	25,20	1.316.599
2026-03-26	5.880	25,22	148.294
2026-03-25	27.116	23,74	643.734
2026-03-24	99	26,35	2.609
2026-03-23	21.715	26,00	564.590
2026-03-20	2.312	25,71	59.442
2026-03-19	100	26,80	2.680
2026-03-18	1.658	27,20	45.098
2026-03-17	2.696	27,10	73.062
2026-03-13	370	26,42	9.775
2026-03-12	746	27,10	20.217
2026-03-09	1.424	26,68	37.992
2026-03-06	1	26,42	26

Top-Fondshalter

Keine Fondsdaten zu dieser Aktie vorhanden.